Home > Health > More than weight loss with Acomplia

< Previous | Next >

More than weight loss with Acomplia

Added: (Wed Sep 13 2006)

Acomplia has plenty of uses and benefits that most weight loss drugs doing rounds of the online pharmacy circuit. It is an anorectic and anti-obesity drug. It blocks cannabinoid receptors, thus reducing your appetite before it takes a 'weighty' toll on you.


Continual research has proved that the hunger pangs that cannabis smokers experience after a bout of smoking, colloquially referred to as the 'munchies', can be curbed to a considerable extent with Acomplia as it blocks the hunger signals that cannabinoids induce in the body.


An anorectic and anti-obesity drug, Acomplia has more uses and benefits that most weight loss drugs offer. It blocks cannabinoid receptors, thus reducing your appetite before it takes a 'weighty' toll on you. With repeated studies, it has often been noted that the hunger pangs that cannabis smokers experience after a bout of smoking, colloquially referred to as the 'munchies', can be curbed to a considerable extent with Acomplia.


Acomplia, also known as Rimonabant, is the first approved drug of it's kind and has done well with those looking at quick weight loss, especially across Europe. In addition to curbing appetite, this drug has also been proved to be an effective antidote to metabolic and cardiovascular disorders. What's more? It also helps heavy smokers curb down their smoking quite effectively, and works best with diet and exercise.



With all the necessary information on this wonder weight loss pill, all you're left with to do is find a decent online pharmacy that offers the pill at a reasonable price with an FDA approval. Who knows? You could be one of the millions of satisfied users of Acomplia? Make sure you consult your doctor first, though.


Submitted by:Daniels Charles Find out more.
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.co.uk together with the url of the release.